Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

被引：14
|
作者：
Hillmen, Peter [1 ]
Muus, Petra [2 ]
Szer, Jeffrey [3 ,4 ]
Hill, Anita [5 ]
Hoechsmann, Britta [6 ,7 ]
Kulasekararaj, Austin
Risitano, Antonio M. [8 ,9 ]
Van Den Neste, Eric [10 ]
Liljeholm, Maria [11 ]
Ebrahim, Kurt S. [12 ]
Bedrosian, Camille L. [13 ]
Gao, Xiang [13 ]
Ames, Donna [13 ]
Socie, Gerard [14 ]
机构：
[1] St James Univ Hosp, Sect Expt Haematol, Level 6,Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England
[2] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands
[3] Royal Melbourne Hosp, Dept Clin Haematol, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, BMT Serv, Melbourne, Vic, Australia
[5] Leeds Teaching Hosp, St James Inst Oncol, Dept Haematol, Leeds, W Yorkshire, England
[6] Univ Ulm, Inst Clin Transfus Med & Immunogenet Ulm, Inst Transfus Med, German Red Cross Blood Transfus Serv Baden Wurtte, D-89069 Ulm, Germany
[7] Univ Hosp Ulm, Ulm, Germany
[8] Kings Coll Hosp London, London, England
[9] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy
[10] Clin Univ UCL St Luc, Dept Hematol, Brussels, Belgium
[11] Univ Umea Hosp, Dept Hematol, S-90185 Umea, Sweden
[12] New England Canc Specialists, Scarborough, ME USA
[13] Alex Pharmaceut Inc, Cheshire, CT USA
[14] Hosp St Louis, AP HP Hematol, Paris, France
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 03期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; IMMUNOGENICITY;
D O I：
10.1002/ajh.24280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E16 / E17
页数：2
相关论文
共 50 条
  • [41] Long-term efficacy and safety of pozelimab monotherapy in patients with paroxysmal nocturnal hemoglobinuria
    Jang, Jun-Ho
    Wong, Raymond
    Weyne, Jonathan
    Chaudhari, Umesh
    Miller, Jutta
    Nguyen, Quang P.
    Griffin, Morag
    IMMUNOBIOLOGY, 2023, 228 (05) : 7 - 7
  • [42] Long-Term Efficacy and Safety of Pozelimab Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Jang, Jun Ho
    Wong, Raymond
    Weyne, Jonathan
    Chaudhari, Umesh
    Miller, Jutta
    Dain, Bradley
    Griffin, Morag
    BLOOD, 2022, 140 : 5309 - 5310
  • [43] Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan
    Takayuki Ikezoe
    Hideyoshi Noji
    Yasutaka Ueda
    Yoshinobu Kanda
    Shinichiro Okamoto
    Kensuke Usuki
    Takahisa Matsuda
    Hirozumi Akiyama
    Akihiko Shimono
    Yuji Yonemura
    Tatsuya Kawaguchi
    Shigeru Chiba
    Yuzuru Kanakura
    Jun‑ichi Nishimura
    Haruhiko Ninomiya
    Naoshi Obara
    International Journal of Hematology, 2022, 115 : 470 - 480
  • [44] Paroxysmal nocturnal hemoglobinuria: A long-term single center experience
    Iori, A. P.
    Torelli, G. F.
    La Rocca, U.
    Barberi, W.
    Lucani, B.
    Mariggio, E.
    Rosati, S.
    Quattrocchi, L.
    Mohamed, S.
    De Luca, G.
    De Propris, M. S.
    Foa, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S416 - S417
  • [45] RESPONSE TO ECULIZUMAB COMBINED WITH CYCLOSPORINE AFTER FAILURE OF ECULIZUMAB MONOTHERAPY IN 2 PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Deldicque, M.
    Knoops, L.
    Van den Neste, E.
    Delannoy, A.
    HAEMATOLOGICA, 2013, 98 : 585 - 586
  • [46] Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria
    Seregina, E. A.
    Tsvetaeva, N. V.
    Nikulina, O. F.
    Zapariy, A. P.
    Erasov, A. V.
    Gribkova, I. V.
    Orel, E. B.
    Ataullakhanov, F. I.
    Balandina, A. N.
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (02) : 144 - 150
  • [47] LONG-TERM EVOLUTION OF TYPE III ERYTHROCYTES DURING ECULIZUMAB TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
    Moncharmont, P.
    Barraco, F.
    Bernaud, J.
    Raffin, A.
    Michallet, M.
    Rigal, D.
    HAEMATOLOGICA, 2012, 97 : 574 - 575
  • [48] Chronic Renal Insufficiency in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Improvement with Eculizumab Treatment in the Long-Term Follow-up of the AEGIS Study
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille
    Valentine, Marye Ellen
    Ozawa, Keiya
    Omine, Mitsuhiro
    BLOOD, 2009, 114 (22) : 783 - 784
  • [49] Evaluation of the Long-Term Safety and Efficacy of Pegcetacoplan Treatment for Paroxysmal Nocturnal Hemoglobinuria Patients: An Extension Study
    Hoffman, Kate
    Machaidze, Zurab
    Yeh, Michael
    Weitz, Ilene C.
    BLOOD, 2021, 138
  • [50] Effects of Eculizumab Treatment on the Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated in Japan
    Ueda, Yasutaka
    Obara, Naoshi
    Yonemura, Yuji
    Noji, Hideyoshi
    Matsuda, Takahisa
    Akiyama, Hirozumi
    Ikezoe, Takayuki
    Chiba, Shigeru
    Kanda, Yoshinobu
    Kawaguchi, Tatsuya
    Shichishima, Tsutomu
    Nakakuma, Hideki
    Okamoto, Shinichiro
    Nishimura, Jun-Ichi
    Kanakura, Yuzuru
    Ninomiya, Haruhiko
    BLOOD, 2017, 130
12345